Bank of New York Mellon Corp

Holdings History for Kiniksa Pharmaceuticals International, plc - COM (KNSA)

Symbol: KNSA on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2024		0%	$0	0	-112,580	-100%		Q2 2024
3/31/2024	0%	0%	$2.22M	113K	-20,973	-15.7%	$19.73	Q1 2024
12/31/2023	0%	0%	$2.34M	134K	-13,015	-8.88%	$17.54	Q4 2023
9/30/2023	0%	+0%	$2.55M	147K	+17,790	+13.8%	$17.37	Q3 2023
6/30/2023	0%	+0%	$1.81M	129K	+828	+0.65%	$14.08	Q2 2023
3/31/2023	0%	+0%	$1.38M	128K	+603	+0.47%	$10.76	Q1 2023
12/31/2022	0%	+0%	$1.91M	127K	+1,819	+1.45%	$14.98	Q4 2022
9/30/2022	0%	+0%	$1.61M	126K	+4,966	+4.12%	$12.84	Q3 2022
6/30/2022			$1K	75			$13.33^*	Q2 2022
6/30/2022	0%	0%	$1.17M	121K	-16,364	-12%	$9.70	Q2 2022
3/31/2022			$1K	75			$13.33^*	Q1 2022
3/31/2022	0%	+0%	$1.36M	137K	+3,020	+2.26%	$9.95	Q1 2022
12/31/2021	0%	0%	$1.58M	134K	-1,091	-0.81%	$11.77	Q4 2021
9/30/2021	0%	+0%	$1.54M	135K	+3,638	+2.77%	$11.39	Q3 2021
6/30/2021	0%	0%	$1.83M	131K	-3,056	-2.27%	$13.94	Q2 2021
3/31/2021	0%	0%	$2.49M	134K	-2,448	-1.79%	$18.52	Q1 2021
12/31/2020	0%	+0%	$2.42M	137K	+45,909	+50.5%	$17.67	Q4 2020
9/30/2020	0%	+0%	$1.39M	91K	+13,437	+17.3%	$15.32	Q3 2020
6/30/2020	0%	+0%	$1.98M	77.5K	+29,295	+60.8%	$25.48	Q2 2020
3/31/2020	0%	+0%	$747K	48.2K	+1,998	+4.32%	$15.49	Q1 2020
12/31/2019	0%	0%	$512K	46.2K	-5,989	-11.5%	$11.08	Q4 2019
9/30/2019	0%	0%	$445K	52.2K	-4,158	-7.38%	$8.52	Q3 2019
6/30/2019	0%	+0%	$764K	56.4K	+9,427	+20.1%	$13.55	Q2 2019
3/31/2019	0%	+0%	$848K	46.9K	+26,374	+128%	$18.06	Q1 2019
12/31/2018	0%	+0%	$578K	20.6K	+3,499	+20.5%	$28.10	Q4 2018
9/30/2018	0%	+0%	$435K	17.1K	+17,071	NEW	$25.48	Q3 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.